Evidence map›Paper›PMID 29932109›Full record

ReviewMicroorganisms2018

PBP4: A New Perspective on

Thaina M da Costa, Carolina R de Oliveira, Henry F Chambers, Som S Chatterjee

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Mislocalization of PBPs inMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Immune escape ofFrontiers in cellular and infection microbiology · 2025
    Review
  10. Review
  11. Kinship analysis ofVeterinary world · 2024
    Article
  12. Skin secretions of Leptodactylidae (Anura) and their potential applications.The journal of venomous animals and toxins including tropical diseases · 2024
    Review
  13. Article
  14. Community-Acquired Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Targeting the Achilles' Heel of Multidrug-ResistantInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Thaina M da CostaDivision of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Bldg. 30, San Francisco, CA 94110, USA. dacosta.tmiranda@gmail.com.ORCID 0000-0002-3660-1786
Carolina R de OliveiraDivision of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Bldg. 30, San Francisco, CA 94110, USA. carolinaroberte@gmail.com.
Henry F ChambersDivision of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Bldg. 30, San Francisco, CA 94110, USA. Henry.Chambers@ucsf.edu.
Som S ChatterjeeDivision of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Bldg. 30, San Francisco, CA 94110, USA. som.chatterjee@ucsf.edu.
San Francisco General Hospital · USUniversidade Federal do Rio de Janeiro · BR

Funding

Novel Mechanisms of Beta-lactam Resistance in Staph AureusR01AI100291 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CHATTERJEE, SOM, HENRY CHAMBERS, HENRY F · 2013 to 2023
$5.1M
NIAID NIH HHS R01 AI100291
6 · The paper itself

Abstract

β-lactam antibiotics are excellent drugs for treatment of staphylococcal infections, due to their superior efficacy and safety compared to other drugs. Effectiveness of β-lactams is severely compromised due to resistance, which is widespread among clinical strains of

Indexed as

Penicillin Binding Protein 4Staphylococcus aureusβ-lactam resistance

Identifiers

PMID29932109
PMCPMC6164785
OpenAlexW2808876981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.